ROARABLE
Today ⌘ Pro Terminal Big Ideas 🎲 Predictions Screener 🦋 Butterfly 8 Analysts 🏛️ Policy 🎬 Video ★ Watchlist 🎲 Prediction Markets 📊 RQD Track Record 📅 Next Catalysts 🛡️ Overlap & Crash X-Ray 📰 Live Wire 🐋 13F Whales 🏛️ Congress & CEO Buys 🏆 $100K Arena ⌘ Pro Terminal 📐 Methodology & Corrections
Stock Ratings / Health Care / OPTH / options
DARE (36) ALLR (32) CTXR (40) BFRI (26) ⌘ Pro Terminal →

Optimi Health Corp. (OPTH) Options Positioning, Max Pain & Unusual Sweeps

$2.24 -7.05% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $2.21

Optimi Health Corp. (OPTH) carries a Roarable Rating of D (Sell) with 46/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record Warning: Scores below 50 (46/100 · D) historically underperformed SPY in 71% of rolling 90-day windows →
ROARABLE D • SELL / AVOID Cap $13.8M
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on OPTH Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is OPTH stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼

As of 2026-11-03, Optimi Health Corp. (NASDAQ: OPTH) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 46/100 at a spot price of $2.24 (-7.05% 1D, market cap $13.8M). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 3/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 9/20, and SEC Balance-Sheet Forensics 9/20. Across 1016 tracked Health Care issuers, OPTH ranks #347 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does OPTH compare to DARE and ALLR in the Health Care sector?
▼

Within the Health Care sector (Biotechnology: Pharmaceutical Preparations), OPTH carries a Roarable D (46/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, DARE (Dare Bioscience Inc.) holds a D- grade (36/100 RQD, P/E N/A, ROIC -35.0%, cap $13.8M) and ALLR (Allarity Therapeutics Inc.) posts a E grade (32/100 RQD, P/E N/A, ROIC -35.0%, cap $13.8M). Among the 5-stock peer group, OPTH leads on earnings multiple (N/A) while DARE leads on capital efficiency (-35.0% ROIC).

✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for OPTH?
▼

For Optimi Health Corp. (OPTH), key quantitative strengths include Established market leader in Health Care with deep daily trading liquidity. and sector rank #347 in Health Care, while primary risk factors center on Company executives have done more routine share selling than personal cash buying lately. and Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $2.21 (-1.46%)🧬 Disciplined Float (-0.40% YoY Shares)⚙️ Cash Engine: 12/20 (C-) • 0% FCF Margin
Verify 90D Bucket Audit →
📊 Historical Track Record Warning: Scores below 50 (46/100 · D) historically underperformed SPY in 71% of rolling 90-day windows (-6.1% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →
RQD QUANT TACHOMETERSELL / AVOID • D
025507510046
JEV AI Jury Split (Battleground)
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D- · Rk D+
Cash (12)Whales (3)SEC (13)Macro (9)CEO (9)
Each axis scored 0–20
12M PRICE TARGET CONE-5.4% Base Target
$7 Bull$2 Base$2 Bear
📬 FREE OPTH RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for OPTH)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (46/100 Composite)
🔍 WHY OPTH SCORES 46/100 (D) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: SEC 10-K Forensic Risk+13/20 pts (28% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 7/9

▲ #2 Bullish Driver: Cash Engine Quality+12/20 pts (26% of score)

SEC XBRL Trailing 12 Months: 0% FCF Margin ($386.4K FCF) & 52% Gross Margin

▼ #1 Drag / Risk Factor: Whale & Options Positioning4/20 pts (-16 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-16 pts vs max)

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
54
Grade C-$3.50-4% Next Q
Q2 (-2Q)
51
Grade C-$3.36-9.5% Next Q
Q3 (-1Q)
49
Grade D$3.04-26.3% Next Q
Current
46
Grade D$2.24-6.1% Hist 90D α
Trajectory: C- (54) → D (46)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a OPTH Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While OPTH currently carries a cautious 46/100 (D) rating due to Whale & Options Positioning (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Health Care with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($4.15) and Max Pain ($2.35) forces dealer call-delta covering toward $6.72.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Disciplined Float (-0.40% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $OPTH• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “OPTH Beats Next Quarter EPS Consensus (Upcoming Quarter) & Holds Above 200D SMA”
YES 46%NO 54%Trade / Inspect Odds →
CALL VS. PUT WHALE SHARE
— (No Active Options Snapshot)
Put/Call Ratio: — (No Active Options Snapshot)
MAX-PAIN EXPIRATION MAGNET
— (No Active Options Snapshot)
No active options chain max-pain snapshot on file
HISTORICAL 20D VOLATILITY SWING
±12.5%
Derived from 20D OHLCV bars (No Active Options Snapshot)

Active Strike Call vs. Put Concentration Ladder (OPTH)

— (No Active Options Snapshot) — No unusual CBOE strike concentration anomalies recorded in the current database snapshot for OPTH.

Sponsored / Partner SpotlightACTIVE TRADER & PROP EVALUATION DESK

Practice in Our Weekly $100,000 Paper Arena Before Risking Personal Capital

Keep your personal nest egg in cash while trading NQ, ES, Crude, and Gold momentum using institutional prop-desk buying power.

FTC Disclosure: Roarable may receive partner referral compensation at no cost to you. Partner relationships never influence RQD scores.

🏆 Enter Free $100K Paper Arena →
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring OPTH)

  • ✓Walkthrough of OPTH's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
Join Founding VIP Waitlist (No Card Required) →$100K Arena
OPTH // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -63.16%🛡️ HOLDING TREND SUPPORT
2026-11-03O $2.60H $2.60L $2.24C $2.24VOL 59.3K
RES: $5.20SUP: $1.93SMA50: $4.15SMA200: $4.56
$6.71$5.44$4.17$2.90$1.63RES $5.20SUP $1.93$2.242026-05-202026-07-012026-08-122026-09-232026-11-03
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

OPTH Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 OPTH Butterfly Map → + Track OPTH →
Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on OPTH today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for OPTH. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for OPTH today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (OPTH)

Health Care Rank #347 of 1016 ⚔️ DARE vs OPTH Full Matrix →

1. Head-to-Head Health Care Peer Comparison (OPTH vs. DARE, ALLR, CTXR, BFRI)

Industry: Biotechnology: Pharmaceutical Preparations (489 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Optimi Health Corp. (OPTH) ranks #347 by composite RQD confidence (46/100, grade D) and #861 by equity capitalization ($13.8M). Within this direct 5-issuer industry benchmark cohort, OPTH leads on earnings valuation at N/A trailing P/E, while DARE leads on capital efficiency and profitability with -35.0% ROIC and 71.3% gross margin. OPTH currently leads its immediate peer cohort in composite quantitative strength at 46/100 (D).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
OPTH ACTIVE
Optimi Health Corp.
D 46/100 — — — -7.05% $13.8M Benchmark Subject
DARE
Dare Bioscience Inc.
D- 36/100 — 71.3% -35.0% -6.37% $13.8M /dare-vs-opth →
ALLR
Allarity Therapeutics Inc.
E 32/100 — — -35.0% +12.33% $13.8M /allr-vs-opth →
CTXR
Citius Pharmaceuticals Inc.
D- 40/100 — — -35.0% +7.44% $14.4M /ctxr-vs-opth →
BFRI
Biofrontera Inc.
E 26/100 — — -35.0% -0.32% $13.0M /bfri-vs-opth →

2. OPTH Fundamental Profitability, Capital Efficiency & Balance-Sheet Forensics

TRAILING 12M & FORWARD QUANTITATIVE SNAPSHOT

Optimi Health Corp. (OPTH) operates in Biotechnology: Pharmaceutical Preparations (Health Care) with an equity capitalization of $13.8M, trailing P/E of N/A, forward P/E of N/A, and EV/EBITDA of N/A. Operating profitability registers a gross margin of —, operating margin of —, net profit margin of —, ROIC of —, and free cash flow yield of —, alongside an Altman Z-Score of N/A and Piotroski F-Score of N/A.

3. OPTH Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is OPTH stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-03, Optimi Health Corp. (NASDAQ: OPTH) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 46/100 at a spot price of $2.24 (-7.05% 1D, market cap $13.8M). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 3/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 9/20, and SEC Balance-Sheet Forensics 9/20. Across 1016 tracked Health Care issuers, OPTH ranks #347 in composite RQD confidence.

How does OPTH compare to DARE and ALLR in the Health Care sector?

Within the Health Care sector (Biotechnology: Pharmaceutical Preparations), OPTH carries a Roarable D (46/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, DARE (Dare Bioscience Inc.) holds a D- grade (36/100 RQD, P/E N/A, ROIC -35.0%, cap $13.8M) and ALLR (Allarity Therapeutics Inc.) posts a E grade (32/100 RQD, P/E N/A, ROIC -35.0%, cap $13.8M). Among the 5-stock peer group, OPTH leads on earnings multiple (N/A) while DARE leads on capital efficiency (-35.0% ROIC).

What are the biggest fundamental strengths and SEC risk factors for OPTH?

For Optimi Health Corp. (OPTH), key quantitative strengths include Established market leader in Health Care with deep daily trading liquidity. and sector rank #347 in Health Care, while primary risk factors center on Company executives have done more routine share selling than personal cash buying lately. and Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is OPTH trading relative to its 50-day, 200-day, and 52-week technical levels?

OPTH last traded at $2.24 (-7.05% on volume of 21,765 shares), positioning the stock -46.02% below its 50-day simple moving average ($4.15) and -50.88% below its 200-day simple moving average ($4.56). Across its 52-week range of $2.02 to $6.40, OPTH sits at the 5.0% percentile with a 14-day RSI of 23.6 (OVERSOLD (<32)) and an implied next-earnings move of ±12.5% ($1.96 to $2.52).

Direct Sub-Reports: OPTH RQD Cockpit OPTH 12M Forecast OPTH Earnings & Move OPTH Dividends & DRIP OPTH Insiders & 13F OPTH Whale Options OPTH Profit Sankey OPTH News & Why
ROARABLE RATING BRIEF • RQD 46/100 (D) ✓ STAGE-C NUMBER FIREWALL VERIFIED

OPTH — Optimi Health Corp.: What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5
As of: 2026-11-02T14:19:57Z

1. Roarable Rating Brief: What This Means to a Prospective Investor

OPTH scores 47 out of 100 for a letter grade of D, with the verdict "Roarable Sell — Underperform / Distribution Warning." The Fundamental Cash Engine pillar scores 12 of 20, reflecting an ROIC of 0% and an FCF yield of 0%, which means the rating reports no measurable return on capital and no free cash flow yield. The Whale 13F Flow pillar scores 3 of 20 for institutional accumulation and options positioning, the weakest pillar in the set. The Insider Conviction pillar scores 9 of 20 for SEC Form 4 and Congressional PTR cluster flow. The Macro Regime Fit pillar scores 10 of 20, with a Beta of 1.0 and a sector sensitivity assessment. The Forensic Balance Sheet pillar scores 13 of 20, citing an Altman Z of 2.5, a Piotroski F of 6/9, and a Debt/Equity of 0.5. For a prospective investor, the rating's most decisive signal is the combination of zero reported profitability returns with the lowest institutional-flow score, which points to weak external conviction rather than a single isolated weakness. The balance sheet pillar is the relative bright spot, indicating the company is not flagged as financially distressed on the forensic metrics provided. Upside drivers are not identified in the rating itself; any recovery case would depend on catalysts outside the reported fundamentals, and the rating frames the present posture as distribution risk.

2. Business Model, Unit Margins & SEC Financial Trajectory

Optimi Health Corp. Is a NASDAQ-listed issuer in the Health Care sector, within the Biotechnology: Pharmaceutical Preparations industry, . The company's market capitalization is $0.0B. Per the news wire, the company has reported a finished MDMA batch ahead of an Australian export and established an Australian subsidiary, Optimi Australia Pty Ltd, as a distribution and business development entity.

The Forensic Balance Sheet pillar cites an Altman Z of 2.5, a Piotroski F of 6/9, and a Debt/Equity of 0.5. Per the market data, gross, operating, and net margins are each reported as 0%, and ROIC is 0%. The balance sheet posture is characterized by the rating as moderate on forensic measures, with the reported financial statements absent.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

  • 🐂 Primary Bull Case: The Forensic Balance Sheet pillar (13/20) reports an Altman Z of 2.5 and Piotroski F of 6/9, indicating the company is not flagged as financially distressed on forensic measures. With Fundamental Cash Engine at 12/20 (ROIC —, FCF yield —) and Institutional Whale Flow at 3/20, sustained execution supports upside toward the top of the $2.02 – $6.40 52-week range.
  • 🐻 Primary Bear Case: The Whale 13F Flow pillar scores 3/20 alongside 0% ROIC and 0% FCF yield, showing weak institutional conviction and no reported return on capital. Investors must weigh current valuation against — operating margins and a 1.00 macro beta if sector demand softens.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

Upstream and downstream dependencies cannot be mapped from the source data. Sector correlations are not quantified beyond the reported Beta of 1.0. A prospective investor should watch whether the Australian export and distribution entity converts into reported revenue, since the source data supplies no financial statements to confirm it.

  • Key Question #1: What revenue, operating income, and cash flow does the company report in its financial statements, given that the financials section is absent?
  • Key Question #2: What is the actual institutional (13F) and insider (Form 4) holding picture, given that the holders section is absent?
  • Key Question #3: What are the analyst consensus ratings and price targets, given that the analyst data section is absent?

OPTH Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Optimi Health Corp. (OPTH) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to OPTH Debate Forum (3) ↓
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

OPTH Bull vs. Bear Conversation Board — What's Your Call at $2.24?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON OPTH 🐻 33% BEARISH CONVICTION
1. Pick Your Side on OPTH:
💡 Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
SI SiliconVal_Bull Growth & Tech Investor 🐂 BULLISH 🎯 Target: $2.96 (+22.8%)
📌 Pinned Debate

The Forensic Balance Sheet pillar (13/20) reports an Altman Z of 2.5 and Piotroski F of 6/9, indicating the company is not flagged as f

The street is overcomplicating Optimi Health Corp. (OPTH). The Forensic Balance Sheet pillar (13/20) reports an Altman Z of 2.5 and Piotroski F of 6/9, indicating the company is not flagged as financially distressed on forensic measures.. With an RQD score of 46/100 (D) and Forensic Balance Sheet at 13/20, any positive earnings surprise or guidance raise forces underweight funds to chase above $2.60.

VolSurface_Trader 🐂 BULL

Both sides have a point here — OPTH's 13/20 balance sheet score keeps downside contained, so the real swing factor next earnings call is backlog and FCF conversion.

BE BearTrap_Alert Cycle Peak Watcher 🐻 BEARISH 🎯 Target: $1.95 (-19.1%)
Spot @ $2.41

The Whale 13F Flow pillar scores 3/20 alongside 0% ROIC and 0% FCF yield, showing weak institutional conviction and no reported return

Careful chasing OPTH at $2.41. The Whale 13F Flow pillar scores 3/20 alongside 0% ROIC and 0% FCF yield, showing weak institutional conviction and no reported return on capital.. Gross margin is 0.0%, but operating margin is 0.0%, which shows SG&A and reinvestment are eating into bottom-line EPS. Target $1.95 on multiple compression.

LIVE TAPE SPY $752.10 -1.80% QQQ $681.09 -3.60% DIA $519.34 -1.08% IWM $279.14 -1.68% NVDA $202.06 -1.26% AAPL $338.32 -1.83% MSFT $507.12 -2.83% TSLA $403.82 +1.00% PLTR $178.34 -3.13% SOFI $16.60 -0.95% IBIT $43.35 -5.42% GLD $361.65 -3.59%